Skip to search.
 TSX Up 0.40% TSX Ventures Down 1.68%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
0.31 0.00(0.00%) May 27, 3:58PM EDT
Prev Close:0.31
Open:0.31
Bid:0.30 x 500
Ask:1.49 x 5000
1y Target Est:1.00
Beta:1.14964
Earnings Date:Aug 3 - Aug 8 (Est.)
Day's Range:0.31 - 0.34
52wk Range:0.25 - 1.92
Volume:59,492
Avg Vol (3m):160,395
Market Cap:7.48M
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTH 0.00%7.48M
LLYDown 0.70%79.13B
PFEUp 0.52%209.90B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.12
Quarterly EPS Est (Jun-16) :-0.19
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback